Sripal Bangalore at [NYU Langone Medical Center]

Sripal Bangalore, MD

  • Specialties: Interventional Cardiology, Cardiology
  • Languages: English, Hindi
  • Phone: 212-263-5656

About Me

Conditions and Treatments

mitral valve disease, acute coronary syndrome, critical limb ischemia, peripheral vascular disease (PVD), high blood pressure disorder, atrial septal defect (ASD), carotid stenosis, coronary heart disease, renal artery stenosis, heart attack, arterial occlusive disease, aortic valve disease, pulmonary stenosis, peripheral vascular disease (PVD), heart valve diseases, carotid artery disease, aortic valve stenosis, heart disease, claudication, mitral regurgitation (MR), mitral valve stenosis, aortic valve insufficiency, cardiac catheterization
Show More Conditions

Credentials

Positions

  • Associate Professor, Department of Medicine

Board Certifications

    2009
  • AB Internal Medicine (Interventional Cardiology)
    2008
  • AB Internal Medicine (Cardiovascular Disease)
    2005
  • AB Internal Medicine - Internal Medicine

Education and Training

  • 2010
  • Fellowship, Peter Bent Brigham Hospital, Interventional Card.
  • 2008
  • Fellowship, St. Luke's-Roosevelt Hospital Center, Cardiovascular Med
  • 2000
  • MD from Bangalore University

Departments

Locations and Appointments

60 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Cigna EPO/POS
  • Cigna PPO
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield Healthy NY
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis Child Health
  • Fidelis Exchange
  • Fidelis Family Health
  • Fidelis Medicaid
  • Fidelis Medicare
  • GHI CBP
  • HIP Access I
  • HIP Access II
  • HIP Child Health
  • HIP EPO/PPO
  • HIP HMO
  • HIP Medicaid
  • HIP Medicare
  • HIP POS
  • HealthPlus Child Health (Amerigroup)
  • HealthPlus Family Health (Amerigroup)
  • HealthPlus Medicaid (Amerigroup)
  • HealthRepublic
  • HealthSmart (WTC)
  • Humana Medicare
  • Local 1199 PPO
  • MagnaCare PPO
  • Medicare
  • MetroPlus Child Health
  • MetroPlus Exchange Plans
  • MetroPlus Family Health
  • MetroPlus Medicaid
  • NY Medicaid
  • NYS Empire Plan
  • Oscar
  • Oxford Exchange
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • Tricare
  • United Exchange- Compass
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • WellCare Child Health
  • WellCare Family Health
  • WellCare Medicaid
  • WellCare Medicare
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.

NYU Cardiac Catheterization Associates
550 1st Avenue, 14th Floor
New York, NY 10016

Contact

Phone: 212-263-5656

Cardiac Catheterization Laboratory

Contact

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

My Research

Dr. Bangalore's main research interests are in design and conduct of large-scale clinical trials testing comparative effectiveness strategies for acute coronary syndromes, structural/valvular heart disease, coronary artery disease with a special interest in coronary artery restenosis and hypertension. In addition, his research also focuses on the use of Electronic Health Records (EHR) to test comparative effectiveness of treatment strategies in a real-world setting and the use of robust methodologies for meta analyses and systematic reviews.

Dr. Bangalore is the PI of a multicenter, international, randomized controlled trial conducted to define the role of an invasive approach in patients with stable ischemic heart disease and substantial ischemia and chronic kidney disease (eGFR <30 or on dialysis). Patients with advanced CKD and moderate to severe ischemia on stress testing will be randomized to INV strategy of cath with optimal revascularization along with optimal medical therapy or to a CON strategy of optimal medical therapy alone with cath reserved for OMT failure. http://clinicaltrials.gov/ct2/show/NCT01985360

Publications

  • Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Disease

    Bangalore, Sripal; Guo, Yu; Samadashvili, Zaza; Blecker, Saul; Xu, Jinfeng; Hannan, Edward L 2015 Mar; ?-?, New England journal of medicine — id: 1505922, year: 2015, page: ?, stat: JOURNAL ARTICLE
  • Trend in percutaneous coronary intervention volume following the COURAGE and BARI-2D trials: Insight from over 8.1 million percutaneous coronary interventions

    Bangalore, Sripal; Gupta, Navdeep; Genereux, Philippe; Guo, Yu; Pancholy, Samir; Feit, Frederick 2015 Jan; 6-10, International journal of cardiology — id: 1462382, year: 2015, page: 6, stat: JOURNAL ARTICLE
  • The reply

    Bangalore, Sripal; Schwamm, Lee; Smith, Eric E; Singh, Inder M; Liang, Li; Fonarow, Gregg C; Bhatt, Deepak L 2015 Mar; e15-e16, American journal of medicine — id: 1473612, year: 2015, page: e15, stat: Letter
Read All Publications (305)